- Used for treatment of lung cancer.
- Bottle of 30 tablets.
- Erlotinib 25mg,100mg,150mg.....
- Product Of Natco Company - Erlonat
- Product Of Roche Company - Tarceva
Erlonat-Erlotinib Erlonat belongs to a class of medications called
Kinase inhibitors and contains erlotinib. It is used for the treatment of
non-small cell lung cancer and in combination with Gemcitabine, is used for
the treatment of pancreatic cancer which spreads to adjacent tissues of the
The action mechanism of the medicine is as follows:
Functions by blocking the action of an abnormal protein to slow down the
growth of cancer cells
Available in 25 mg, 100 mg & 150 mg tablets
Usually 150 mg tablet is administered, at least an
hour before or two hours after the ingestion of food, for curing pancreatic
non-small cell lung cancer. Erlonat is usually given as 100 mg tablets, at
least an hour before or two hours after the intake of food, for curing of
pancreatic cancer, in combination with gemcitabine.
Symptoms of overdose may include diarrhea and rash
Precautions and warnings:
The medicine should not be taken without consulting
the doctor if the patient has liver disease, lung or breathing problems
(other than lung cancer). Do not take aspirin, or products containing
aspirin, unless prescribed by the doctor Patient must take Erlonat at
substantial time gap, if antacids are also being taken If the patient is
allergic to the medicine or any of its constituents, then intake is not
Erlonat consumption should avoided if the patient is pregnant or breast
feeding the child. Doctor consultation suggested for use of birth control
during treatment with Erlonat. It is not yet established whether Erlonat
passes into breast milk or not. Drug Interactions
The following drugs may interact with Erlonat :
Atazanavir Nelfinavir Indinavir Saquinavir Ritonavir
Rifampin Rifabutin Rifapentine Clarithromycin Nefazodone Telithromycin
Troleandomycin Carbamazepine Phenobarbital Phenytoin Ketoconazole
Itraconazole VoriconazoleSt. John's Wort Side effects of the medicine are as
follows: Breathing Closing of the throat Swelling of the lips, tongue, face
or hives Shortness of breath Increased coughing Fever and chest pain Severe
or persistent nausea Vomiting and loss of appetite Diarrhea Eye pain or
irritation Skin rash, dryness, itching and acne Weakness Blistering and
peeling Dry or cracked skin Itching, tenderness or burning of the skin
Growth of eyelashes on the inside of the eyelid Unusual bruising or bleeding
Note: Erlonat is a prescription drug and should be used under proper medical
guidance and advice. Do not share the medicine with others, since they may
be suffering from a problem that is not effectively treated by this drug.
Note: Erlonat - Erlotinib - Tarceva is a
prescription drug and should be used under proper medical guidance and
Do not share the medicine with others, since they may be suffering from a
problem that is not effectively treated by this drug.